Trial Profile
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2023
Price :
$35
*
At a glance
- Drugs Salmeterol (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 22 Aug 2007 Status changed from in progress to completed.
- 31 Dec 2005 New trial record.